Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Phathom Pharmaceuticals (PHAT) Leases: 2022-2025

Historic Leases for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Sep 2025 value amounting to $2.7 million.

  • Phathom Pharmaceuticals' Leases rose 223.41% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 223.41%. This contributed to the annual value of $613,000 for FY2024, which is 58.44% down from last year.
  • Phathom Pharmaceuticals' Leases amounted to $2.7 million in Q3 2025, which was up 208.59% from $873,000 recorded in Q2 2025.
  • Over the past 5 years, Phathom Pharmaceuticals' Leases peaked at $2.7 million during Q3 2025, and registered a low of $388,000 during Q1 2025.
  • Moreover, its 3-year median value for Leases was $1.3 million (2024), whereas its average is $1.3 million.
  • Examining YoY changes over the last 5 years, Phathom Pharmaceuticals' Leases showed a top increase of 223.41% in 2025 and a maximum decrease of 69.30% in 2025.
  • Quarterly analysis of 4 years shows Phathom Pharmaceuticals' Leases stood at $2.3 million in 2022, then tumbled by 35.51% to $1.5 million in 2023, then plummeted by 58.44% to $613,000 in 2024, then soared by 223.41% to $2.7 million in 2025.
  • Its Leases was $2.7 million in Q3 2025, compared to $873,000 in Q2 2025 and $388,000 in Q1 2025.